21 results on '"Abelli, Massimo"'
Search Results
2. Immune Control of Human Cytomegalovirus (HCMV) Infection in HCMV-Seropositive Solid Organ Transplant Recipients: The Predictive Role of Different Immunological Assays.
- Author
-
Zavaglio, Federica, Cassaniti, Irene, d'Angelo, Piera, Zelini, Paola, Comolli, Giuditta, Gregorini, Marilena, Rampino, Teresa, Del Frate, Lucia, Meloni, Federica, Pellegrini, Carlo, Abelli, Massimo, Ticozzelli, Elena, Lilleri, Daniele, and Baldanti, Fausto
- Subjects
HUMAN cytomegalovirus ,TRANSPLANTATION of organs, tissues, etc. ,DENDRITIC cells ,PEPTIDES ,FLOW cytometry ,T cells - Abstract
Human cytomegalovirus (HCMV) infection remains a major complication for solid organ transplant recipients (SOTRs). The aim of this study was to evaluate the role of HCMV-specific T cell immunity measured at the time of the HCMV-DNA peak in predicting the spontaneous clearance of infection. The performance of cytokine flow cytometry using infected dendritic cells (CFC-iDC), infected cell lysate (CFC-iCL) and pp65 peptide pool (CFC-pp65 pool) as stimuli, as well as ELISPOT assays using infected cell lysate (ELISPOT-iCL) and the pp65 peptide pool (ELISPOT-pp65 pool), was analysed. Among the 40 SOTRs enrolled, 16 patients (40%) required antiviral treatment for an HCMV infection (Non-Controllers), while the others spontaneously cleared the infection (Controllers). At the HCMV-DNA peak, the number of HCMV-specific CD4
+ T cells detected by the CFC-iDC, CFC-iCL and CFC-pp65 pool assays in Controllers was higher than that detected in Non-Controllers, while no difference was observed in terms of HCMV-specific CD8+ T cell response. The same trend was observed when the HCMV-specific T cell response was measured by ELISPOT-iCL and ELISPOT-pp65 pool. We observed that the CD4+ CFC-pp65 pool assay was the best predictor of self-resolving HCMV infection at the time of the HCVM-DNA peak. The CFC-pp65 pool assay is able to discriminate between CD4+ and CD8+ T cell responses and could be used in daily clinical practice. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
3. Impediments to Heart Transplantation in Adults With MELAS:m.3243A>G Cardiomyopathy
- Author
-
Di Toro, Alessandro, primary, Urtis, Mario, additional, Narula, Nupoor, additional, Giuliani, Lorenzo, additional, Grasso, Maurizia, additional, Pasotti, Michele, additional, Pellegrini, Carlo, additional, Serio, Alessandra, additional, Pilotto, Andrea, additional, Antoniazzi, Elena, additional, Rampino, Teresa, additional, Magrassi, Lorenzo, additional, Valentini, Adele, additional, Cavallini, Anna, additional, Scelsi, Laura, additional, Ghio, Stefano, additional, Abelli, Massimo, additional, Olivotto, Iacopo, additional, Porcu, Maurizio, additional, Gavazzi, Antonello, additional, Kodama, Takahide, additional, and Arbustini, Eloisa, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Performance of Whole Blood Stimulation Assays for the Quantification of SARS-CoV-2 Specific T-Cell Response: A Cross-Sectional Study
- Author
-
Bergami, Federica, primary, Arena, Francesca, additional, Pattonieri, Eleonora Francesca, additional, Gregorini, Marilena, additional, Meloni, Federica, additional, Abelli, Massimo, additional, Ticozzelli, Elena, additional, Testa, Giorgia, additional, Lilleri, Daniele, additional, Cassaniti, Irene, additional, and Baldanti, Fausto, additional
- Published
- 2022
- Full Text
- View/download PDF
5. Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients
- Author
-
Cassaniti, Irene, primary, Gregorini, Marilena, additional, Bergami, Federica, additional, Arena, Francesca, additional, Sammartino, Josè Camilla, additional, Percivalle, Elena, additional, Soleymaninejadian, Ehsan, additional, Abelli, Massimo, additional, Ticozzelli, Elena, additional, Nocco, Angela, additional, Minero, Francesca, additional, Pattonieri, Eleonora Francesca, additional, Lilleri, Daniele, additional, Rampino, Teresa, additional, and Baldanti, Fausto, additional
- Published
- 2022
- Full Text
- View/download PDF
6. Evaluation of Oxidative Stress and Metabolic Profile in a Preclinical Kidney Transplantation Model According to Different Preservation Modalities
- Author
-
Mrakic-Sposta Simona, Vezzoli Alessandra, Cova Emanuela, Ticcozzelli Elena, Montorsi Michela, Greco Fulvia, Sepe Vincenzo, Benzoni Ilaria, Meloni Federica, Arbustini Eloisa, Abelli Massimo, and Gussoni Maristella
- Subjects
Inorganic Chemistry ,Organic Chemistry ,General Medicine ,kidney transplant ,hypothermic machine perfusion ,organ preservation ,ROS ,metabolomic ,EPR ,1H-NMR ,oxidative damage ,Physical and Theoretical Chemistry ,Molecular Biology ,Spectroscopy ,Catalysis ,Computer Science Applications - Abstract
This study addresses a joint nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) spectroscopy approach to provide a platform for dynamic assessment of kidney viability and metabolism. On porcine kidney models, ROS production, oxidative damage kinetics, and metabolic changes occurring both during the period between organ retrieval and implantation and after kidney graft were examined. The 1H-NMR metabolic profile—valine, alanine, acetate, trimetylamine-N-oxide, glutathione, lactate, and the EPR oxidative stress—resulting from ischemia/reperfusion injury after preservation (8 h) by static cold storage (SCS) and ex vivo machine perfusion (HMP) methods were monitored. The functional recovery after transplantation (14 days) was evaluated by serum creatinine (SCr), oxidative stress (ROS), and damage (thiobarbituric-acid-reactive substances and protein carbonyl enzymatic) assessments. At 8 h of preservation storage, a significantly (p < 0.0001) higher ROS production was measured in the SCS vs. HMP group. Significantly higher concentration data (p < 0.05–0.0001) in HMP vs. SCS for all the monitored metabolites were found as well. The HMP group showed a better function recovery. The comparison of the areas under the SCr curves (AUC) returned a significantly smaller (−12.5 %) AUC in the HMP vs. SCS. EPR-ROS concentration (μmol·g−1) from bioptic kidney tissue samples were significantly lower in HMP vs. SCS. The same result was found for the NMR monitored metabolites: lactate: −59.76%, alanine: −43.17%; valine: −58.56%; and TMAO: −77.96%. No changes were observed in either group under light microscopy. In conclusion, a better and more rapid normalization of oxidative stress and functional recovery after transplantation were observed by HMP utilization.
- Published
- 2023
- Full Text
- View/download PDF
7. Kidney Transplants From Donors on Extracorporeal Membrane Oxygenation Prior to Death Are Associated With Better Long-Term Renal Function Compared to Donors After Circulatory Death
- Author
-
Gregorini, Marilena, primary, Ticozzelli, Elena, additional, Abelli, Massimo, additional, Grignano, Maria A., additional, Pattonieri, Eleonora F., additional, Giacomoni, Alessandro, additional, De Carlis, Luciano, additional, Dell’Acqua, Antonio, additional, Caldara, Rossana, additional, Socci, Carlo, additional, Bottazzi, Andrea, additional, Libetta, Carmelo, additional, Sepe, Vincenzo, additional, Malabarba, Stefano, additional, Manzoni, Federica, additional, Klersy, Catherine, additional, Piccolo, Giuseppe, additional, and Rampino, Teresa, additional
- Published
- 2022
- Full Text
- View/download PDF
8. Consensus statement on normothermic regional perfusion in donation after circulatory death: report from the European Society for Organ Transplantation's Transplant Learning Journey
- Author
-
Jochmans, Ina, Hessheimer, Amelia J., Neyrinck, Arne P., Paredes, David, Bellini, Maria Irene, Dark, John H., Kimenai, Hendrikus J. A. N., Pengel, Liset H. M., Watson, Christopher J. E., Abelli, Massimo, Antoine, Corinne, Barrou, Benoît, Bello, Irene, Degezelle, Karlien, De Beule, Julie, De Carlis, Riccado, de Jonge, Jeroen, Foss, Stein, Huurman, Volkert A.L., Knight, Simon R., Lebreton, Guillaume, Ledoux, Didier, Manara, Alex, Miñambres, Eduardo, Rega, Filip, Rubino, Antonio, Ryan, Marian, Sage, Edouard, Savier, Eric, Schotsmans, Paul, Ticozelli, Elena, Vandendriessche, Katrien, Zanierato, Marinella, Project, ESOT Workstream 04 of the TLJ (Transplant Learning Journey), and Surgery
- Subjects
medicine.medical_specialty ,Consensus ,Tissue and Organ Procurement ,Statement (logic) ,MEDLINE ,Regional perfusion ,donation after circulatory death ,Donation after circulatory death ,guidelines ,normothermic regional perfusion ,solid organ transplantation ,Organ transplantation ,Humans ,Medicine ,Intensive care medicine ,Transplantation ,business.industry ,Foundation (evidence) ,Organ Preservation ,Organ Transplantation ,Circulatory death ,Tissue Donors ,Death ,Perfusion ,Donation ,business - Abstract
Normothermic regional perfusion (NRP) in donation after circulatory death (DCD) is a safe alternative to in situ cooling and rapid procurement. An increasing number of countries and centres are performing NRP, a technically and logistically challenging procedure. This consensus document provides evidence-based recommendations on the use of NRP in uncontrolled and controlled DCDs. It also offers minimal ethical, logistical and technical requirements that form the foundation of a safe and effective NRP programme. The present article is based on evidence and opinions formulated by a panel of European experts of Workstream 04 of the Transplantation Learning Journey project, which is part of the European Society for Organ Transplantation. ispartof: TRANSPLANT INTERNATIONAL vol:34 issue:11 pages:2019-2030 ispartof: location:Switzerland status: published
- Published
- 2021
9. Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease
- Author
-
Esposito, Pasquale, primary, Verzola, Daniela, additional, Porta, Edoardo La, additional, Milanesi, Samantha, additional, Grignano, Maria Antonietta, additional, Avella, Alessandro, additional, Gregorini, Marilena, additional, Abelli, Massimo, additional, Ticozzelli, Elena, additional, Rampino, Teresa, additional, and Garibotto, Giacomo, additional
- Published
- 2020
- Full Text
- View/download PDF
10. P1746EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATMENT OF RENAL CHRONIC ANTIBODY MEDIATED REJECTION: A PILOT STUDY
- Author
-
Pattonieri, Eleonora Francesca, primary, Gregorini, Marilena, primary, Viarengo, Gianlcuca, primary, Del Fante, Claudia, primary, Perotti, Cesare, primary, Grignano, Maria Antonietta, primary, Sepe, Vincenzo, primary, Libetta, Carmelo, primary, Abelli, Massimo, primary, Ticozzelli, Elena, primary, and RAmpino, Teresa, primary
- Published
- 2020
- Full Text
- View/download PDF
11. ECMO PRIOR TO DEATH: A NEW CATEGORY OF NHBDS: OP41
- Author
-
Geraci, Paolo, Abelli, Massimo, Dal Canton, Antonio, Raimondi, Maurizio, Braschi, Antonio, Iotti, Giorgio, Maurelli, Marco, Ticozzelli, Elena, Sacchi, Marco, and Costa, Alessandro Nanni
- Published
- 2010
12. FP307MYOSTATIN: A NEW PLAYER IN THE COMPLEXITY OF UREMIC VASCULOPATHY
- Author
-
Esposito, Pasquale, primary, La Porta, Edoardo, additional, Verzola, Daniela, additional, Grignano, Maria Antonietta, additional, Milanesi, Samantha, additional, Calatroni, Marta, additional, Caramella, Elena, additional, Avella, Alessandro, additional, Abelli, Massimo, additional, Ticozzelli, Elena, additional, Rampino, Teresa, additional, and Garibotto, Giacomo, additional
- Published
- 2018
- Full Text
- View/download PDF
13. A retrospective analysis of dermatological lesions in kidney transplant patients
- Author
-
Dal Canton, Antonio, Borroni, Giovanni, Abelli, Massimo, Catherine Klersy, Esposito, Pasquale, Soccio, Grazia, Piotti, Giovanni, Bedino, Giulia, Bosio, Francesca, Rampino, Teresa, Gregorini, Marilena, and Castello, Michela
- Subjects
kidney transplant ,Adult ,Graft Rejection ,Male ,Daclizumab ,Anti-rejection treatment ,Recombinant Fusion Proteins ,skin lesions ,Antibodies, Monoclonal, Humanized ,Skin Diseases ,Basiliximab ,Humans ,Aged ,Retrospective Studies ,Immunosuppression Therapy ,end-stage renal disease ,immunosuppression ,TOR Serine-Threonine Kinases ,Antibodies, Monoclonal ,Middle Aged ,Mycophenolic Acid ,Kidney Transplantation ,Treatment Outcome ,Mycoses ,Virus Diseases ,Immunoglobulin G ,Kidney Failure, Chronic ,Original Article ,Female ,benign tumour ,Immunosuppressive Agents - Abstract
Background & objectives: Kidney transplantation is the best option for patients with end-stage renal disease (ESRD) failure. Prolonged use of immunosuppressive drugs often causes opportunistic infections and malignancies of skin and mucosae, but due to lack of a careful dermatological screening in several transplantation centers the diagnosis and the treatment of dermatological lesions in kidney transplant patients are underestimated. In addition after the introduction of interleukin (IL)-2 -receptor antagonists (basiliximab/daclizumab), mTOR inhibitors and mycophenolate mofetil (MMF)/mycophenolic acid (MPA) in new immunosuppressive protocols only a few studies have analyzed the skin and mucosal lesions in kidney transplant patients. This study was undertaken to evaluate the cutaneous and mucosal diseases after kidney transplantation, and to investigate the association between these and different immunosuppressive protocols and/or demographic features. Methods: A retrospective analysis was done using medical records of kidney transplantation between 2000 and 2009 at the Transplant Unit of Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. The study included 183 patients (M 57.3%, F 42.7%) aged 51.5±11.8 yr) with transplant age 52.3±34.9 months. Induction therapy was basiliximab and steroids based; maintenance therapy included combination-regimes from cyclosporine, tacrolimus, steroids, mycophenolate mofetil (MM), mycophenolic acid (MPA), rapamycin, everolimus. Anti-rejection therapy was steroid and/or thymoglobulines based. Diagnosis of cutaneous disease was made through examination of skin, mucous membranes, nails and hair evaluation. Skin biopsies, specific cultures and serological tests were done when required. Results: Skin and mucosal diseases were reported in 173 (95.7%) of patients; 88 (50.81%) showed viral lesions; 92 (53.01%) immunosuppression-related lesions; 28 (16.39%) benign tumours; 26 (15.3%) precancers /neoplastic lesions; 24 (14.21%) mycosis; 16 (9.29%) cutaneous xerosis, 15 (8.74%) dermatitis, while absence of cutaneous disease was evident only in 8 (4.37%) cases. An association between drug side effects and anti-rejection treatment (P≤0.01) and/or calcineurin-inhibitors (CNI) exposure (P≤0.01) was found. Longer exposure to immunosuppressive drugs (>60 months) was associated with pre-malignancy and malignancy lesions. Interpretation & conclusions: Cutaneous diseases are frequent in kidney transplanted patients. Continuous skin monitoring is necessary to make an early diagnosis and to start appropriate treatment.
- Published
- 2013
14. Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy
- Author
-
Ravaioli, Matteo, primary, Capocasale, Enzo, additional, Furian, Lucrezia, additional, De Pace, Vanessa, additional, Iaria, Maurizio, additional, Spagnoletti, Gionata, additional, Salerno, Maria Paola, additional, Giacomoni, Alessandro, additional, De Carlis, Luciano, additional, Di Bella, Caterina, additional, Rostand, Nguefouet Momo, additional, Boschiero, Luigino, additional, Pasquale, Giovanni, additional, Bosio, Andrea, additional, Collini, Andrea, additional, Carmellini, Mario, additional, Airoldi, Andrea, additional, Bondonno, Gianmarco, additional, Ditonno, Pasquale, additional, Impedovo, Stefano Vittorio, additional, Beretta, Claudio, additional, Giussani, Antenore, additional, Socci, Carlo, additional, Parolini, Danilo Carlo, additional, Abelli, Massimo, additional, Ticozzelli, Elena, additional, Baccarani, Umberto, additional, Adani, Gian Luigi, additional, Caputo, Flavia, additional, Buscemi, Barbara, additional, Frongia, Mauro, additional, Solinas, Andrea, additional, Gruttadauria, Salvatore, additional, Spada, Marco, additional, Pinna, Antonio Daniele, additional, and Romagnoli, Jacopo, additional
- Published
- 2017
- Full Text
- View/download PDF
15. MP809URINARY TRACT INFECTIONS IN EARLY POST KIDNEY TRANSPLANT PERIOD ARE A RISK FACTOR FOR RECURRENT INFECTIONS AND GRAFT FUNCTION DECLINE
- Author
-
Pattonieri, Eleonora Francesca, primary, Corradetti, Valeria, additional, Cannone, Manuela, additional, Contardi, Giada, additional, Gregorini, Marilena, additional, Grignano, Maria Antonietta, additional, Scudeller, Luigia, additional, Abelli, Massimo, additional, Ticozzelli, Elena, additional, and Rampino, Teresa, additional
- Published
- 2017
- Full Text
- View/download PDF
16. SP379UNDERSTANDING KIDNEY TRANSPLANT BONE DAMAGE: A RETROSPECTIVE CROSS SECTIONAL STUDY
- Author
-
Corradetti, Valeria, primary, Pattonieri, Eleonora Francesca, additional, Sileno, Giuseppe, additional, Grignano, Maria Antonietta, additional, Abelli, Massimo, additional, Ticozzelli, Elena, additional, Gregorini, Marilena, additional, and Rampino, Teresa, additional
- Published
- 2017
- Full Text
- View/download PDF
17. 'Why can't I give you my organs after my heart has stopped beating?' An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy
- Author
-
Giannini, Alberto, Abelli, Massimo, Azzoni, Giampaolo, Biancofiore, Gianni, Citterio, Franco, Geraci, Paolo, Latronico, Nicola, Picozzi, Mario, Procaccio, Francesco, Riccioni, Luigi, Rigotti, Paolo, Valenza, Franco, Vesconi, Sergio, Zamperetti, Nereo, Citterio, Franco (ORCID:0000-0003-0489-6337), Giannini, Alberto, Abelli, Massimo, Azzoni, Giampaolo, Biancofiore, Gianni, Citterio, Franco, Geraci, Paolo, Latronico, Nicola, Picozzi, Mario, Procaccio, Francesco, Riccioni, Luigi, Rigotti, Paolo, Valenza, Franco, Vesconi, Sergio, Zamperetti, Nereo, and Citterio, Franco (ORCID:0000-0003-0489-6337)
- Abstract
Donation after circulatory death (DCD) is a valuable option for the procurement of functioning organs for transplantation. Clinical results are promising and public acceptance is quite good in most western countries. Yet, although DCD is widespread in Europe, several problems still persist in Italy as well as in some other countries. This paper aims to describe the main clinical, organisational, ethical and legal issues at stake, bearing in mind the particular situation created by Italian legislation. Currently, as regards DCD, Italy is somewhat different from other countries. Therefore, every effort should be made for the safe and effective implementation of DCD programs: uncontrolled DCD programs should be promoted and encouraged, within the framework of shared and authoritative rules. At the same time, we need to tackle the question of controlled DCD, promoting debate among all involved subjects regarding the fundamental issues of end-of-life care within protocols that best integrate the highest standard of care for the dying and the legitimate interests of those awaiting a life-saving organ.
- Published
- 2016
18. Creation and implantation of acellular rat renal ECM-based scaffolds
- Author
-
Peloso, Andrea, primary, Ferrario, Jacopo, additional, Maiga, Benedetta, additional, Benzoni, Ilaria, additional, Bianco, Carolina, additional, Citro, Antonio, additional, Currao, Manuela, additional, Malara, Alessandro, additional, Gaspari, Annalisa, additional, Balduini, Alessandra, additional, Abelli, Massimo, additional, Piemonti, Lorenzo, additional, Dionigi, Paolo, additional, Orlando, Giuseppe, additional, and Maestri, Marcello, additional
- Published
- 2015
- Full Text
- View/download PDF
19. Impediments to Heart Transplantation in Adults With MELASMT-TL1:m.3243A>G Cardiomyopathy.
- Author
-
Di Toro, Alessandro, Urtis, Mario, Narula, Nupoor, Giuliani, Lorenzo, Grasso, Maurizia, Pasotti, Michele, Pellegrini, Carlo, Serio, Alessandra, Pilotto, Andrea, Antoniazzi, Elena, Rampino, Teresa, Magrassi, Lorenzo, Valentini, Adele, Cavallini, Anna, Scelsi, Laura, Ghio, Stefano, Abelli, Massimo, Olivotto, Iacopo, Porcu, Maurizio, and Gavazzi, Antonello
- Subjects
- *
MELAS syndrome , *HEART transplantation , *CARDIOMYOPATHIES , *MITOCHONDRIAL DNA , *CHRONIC kidney failure , *HEARING disorders , *MUSCLE diseases , *DNA , *GENETIC mutation , *MITOCHONDRIAL encephalomyopathies , *DISEASE complications ,CHRONIC kidney failure complications - Abstract
Background: The heart is commonly involved in maternally inherited mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome caused by the MT-TL1 m.3243A>G mutation of the mitochondrial DNA. Heart transplantation (HTx) is controversial and has rarely been performed with conflicting results.Objectives: We analyzed factors preventing HTx in consecutive adult patients with MELASMT-TL1:m.3243A>G cardiomyopathy diagnosed and followed during the last 23 years in our HTx referral center.Methods: The series consists of 14 unrelated adult probands who were referred for evaluation of cardiomyopathy from 1998 to 2021. None had a suspected diagnosis of MELAS before referral. All patients underwent clinical and genetic visit and counseling, mitochondrial DNA sequencing, cardiovascular investigation (including right heart catheterization and endomyocardial biopsy in 10), multidisciplinary assessment, and biochemical tests. Family screening identified 2 affected relatives.Results: The cardiac phenotype was characterized by hypertrophic, concentric, nonobstructive cardiomyopathy that often evolved into a dilated cardiomyopathy-like phenotype. Of the 14 probands, 7 were potential candidates for HTx, 2 for heart and kidney Tx, and 1 was on the active HTx list for 3 years. None of the 10 probands underwent HTx. One is currently being evaluated for HTx. All had diabetes, hearing loss, and myopathy, and 10 had chronic kidney disease and progressive encephalomyopathy. During follow-up, 10 died from heart failure associated with multiorgan failure within 5 years of the genetic diagnosis.Conclusions: High risk of stroke-like episodes, chronic kidney disease, and wasting myopathy in MELASMT-TL1:m.3243A>G patients prevents activation of plans for HTx. As a result, the management of their cardiomyopathy in this syndromic context remains an unmet clinical need. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
20. A retrospective analysis of dermatological lesions in kidney transplant patients.
- Author
-
Castello, Michela, Gregorini, Marilena, Rampino, Teresa, Bosio, Francesca, Bedino, Giulia, Piotti, Giovanni, Soccio, Grazia, Esposito, Pasquale, Klersy, Catherine, Abelli, Massimo, Borroni, Giovanni, and Canton, Antonio Dal
- Subjects
- *
SKIN diseases , *PRECANCEROUS conditions , *KIDNEY transplant patients , *KIDNEY failure , *DRUG side effects , *THERAPEUTICS - Abstract
Background & objectives: Kidney transplantation is the best option for patients with end-stage renal disease (ESRD) failure. Prolonged use of immunosuppressive drugs often causes opportunistic infections and malignancies of skin and mucosae, but due to lack of a careful dermatological screening in several transplantation centers the diagnosis and the treatment of dermatological lesions in kidney transplant patients are underestimated. In addition after the introduction of interleukin (IL)-2 -receptor antagonists (basiliximab/daclizumab), mTOR inhibitors and mycophenolate mofetil (MMF)/mycophenolic acid (MPA) in new immunosuppressive protocols only a few studies have analyzed the skin and mucosal lesions in kidney transplant patients. This study was undertaken to evaluate the cutaneous and mucosal diseases after kidney transplantation, and to investigate the association between these and different immunosuppressive protocols and/or demographic features. Methods: A retrospective analysis was done using medical records of kidney transplantation between 2000 and 2009 at the Transplant Unit of Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. The study included 183 patients (M 57.3%, F 42.7%) aged 51.5±11.8 yr) with transplant age 52.3±34.9 months. Induction therapy was basiliximab and steroids based; maintenance therapy included combination-regimes from cyclosporine, tacrolimus, steroids, mycophenolate mofetil (MM), mycophenolic acid (MPA), rapamycin, everolimus. Anti-rejection therapy was steroid and/or thymoglobulines based. Diagnosis of cutaneous disease was made through examination of skin, mucous membranes, nails and hair evaluation. Skin biopsies, specific cultures and serological tests were done when required. Results: Skin and mucosal diseases were reported in 173 (95.7%) of patients; 88 (50.81%) showed viral lesions; 92 (53.01%) immunosuppression-related lesions; 28 (16.39%) benign tumours; 26 (15.3%) precancers /neoplastic lesions; 24 (14.21%) mycosis; 16 (9.29%) cutaneous xerosis, 15 (8.74%) dermatitis, while absence of cutaneous disease was evident only in 8 (4.37%) cases. An association between drug side effects and anti-rejection treatment (P≤0.01) and/or calcineurin-inhibitors (CNI) exposure (P=0.01) was found. Longer exposure to immunosuppressive drugs (>60 months) was associated with pre-malignancy and malignancy lesions. Interpretation & conclusions: Cutaneous diseases are frequent in kidney transplanted patients. Continuous skin monitoring is necessary to make an early diagnosis and to start appropriate treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2013
21. Creation and implantation of acellular rat renal ECM-based scaffolds
- Author
-
Andrea Peloso, Paolo Dionigi, Ilaria Benzoni, Massimo Abelli, Alessandro Malara, Carolina Bianco, Gaspari A, Jacopo Ferrario, Alessandra Balduini, Manuela Currao, Antonio Citro, Giuseppe Orlando, Marcello Maestri, Benedetta Maiga, Lorenzo Piemonti, Pathology/molecular and cellular medicine, Peloso, Andrea, Ferrario, Jacopo, Maiga, Benedetta, Benzoni, Ilaria, Bianco, Carolina, Citro, Antonio, Currao, Manuela, Malara, Alessandro, Gaspari, Annalisa, Balduini, Alessandra, Abelli, Massimo, Piemonti, Lorenzo, Dionigi, Paolo, Orlando, Giuseppe, and Maestri, Marcello
- Subjects
Male ,Pathology ,Embryology ,scaffold ,Kidney ,Regenerative medicine ,Extracellular matrix ,Kidney transplantation ,Tissue engineering ,Tissue Scaffold ,Decellularization ,Tissue Scaffolds ,Research Papers ,medicine.anatomical_structure ,tissue engineering ,Rat model ,Perfusion ,medicine.medical_specialty ,kidney ,bioscaffold ,extracellular matrix ,Biomedical Engineering ,kidney transplantation ,regenerative medicine ,Prosthesis Design ,Bioscaffold ,RATS ,Scaffold ,medicine ,Journal Article ,Animals ,Organ bioengineering ,Transplantation ,Tissue Engineering ,Cell-Free System ,business.industry ,Animal ,rat model ,medicine.disease ,Surgery ,Equipment Failure Analysi ,Equipment Failure Analysis ,Rats, Inbred Lew ,organ bioengineering ,Rat ,business ,Developmental Biology - Abstract
Kidney transplantation is the only potentially curative treatment for patient facing end-stage renal disease, and it is now routinely used. Its use is mainly limited by the supply of transplantable donor organs, which far exceeds the demand. Regenerative medicine and tissue engineering offer promising means for overcoming this shortage. In the present study, we developed and validated a protocol for producing acellular rat renal scaffolds. Left kidneys were removed from 26 male Lewis rats (weights: 250–350 g) and decellularized by means of aortic anterograde perfusion with ionic and anionic detergents (Triton X-100 1% and SDS 1%, respectively). 19 scaffolds thus obtained (and contralateral native kidneys as controls) were deeply characterized in order to evaluate the decellularization quality, the preservation of extracellular matrix components and resultant micro-angioarchitecture structure. The other 7 were transplanted into 7 recipient rats that had undergone unilateral nephrectomy. Recipients were sacrificed on post-transplantation day 7 and the scaffolds subjected to histologic studies. The dual-detergent protocol showed, with only 5 h of perfusion per organ, to obtain thoroughly decellularized renal scaffolds consisting almost exclusively of extracellular matrix. Finally the macro- and the microarchitecture of the renal parenchyma were well preserved, and the grafts were implanted with ease. Seven days after transplant, the scaffolds were morphologically intact although all vascular structures were obstructed with thrombi. Production and implantation of acellular rat renal scaffolds is a suitable platform for further studies on regenerative medicine and tissue engineering.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.